Riva Health, a Burlingame, California-based mobile cardiology app provider, raised $15.5M in funding.
The round was led by Menlo Ventures with participation from UCHealth and University of Colorado Innovation Fund, as well as Chicago healthcare investors, Brandon Cruz of GoHealth and Larry Gies of Madison Industries. In conjunction with the funding, Dr. Rich Zane from UCHealth will join Greg Yap from Menlo Ventures on Riva’s board of directors.
The company intends to use the funds to expand operations.
Led by CEO Dag Kittlaus, former co-founder of both Siri and Viv, and Tuhin Sinha, PhD and co-founder of one of the largest cardiovascular research studies in the world, Health eHeart, Riva Health is building a cardiology technology app that measures and manages hypertension.
The application uses fingertip photoplethysmography (PPG) to measure an individual’s blood-pulse waveform (BPW), a signal that shows changes in blood flow volume and intensity. The high-resolution measurement is captured when an individual’s index finger is placed on the camera lens on the back of a phone. This novel technology is coupled with healthcare interventions provided by Riva’s own licensed healthcare providers. The comprehensive hypertension solution can be used for more rapid and high-fidelity remote patient management and to make premium heart healthcare more equitable and accessible.
Riva will launch the beta of its flagship app in the summer of 2021 and is currently hiring for their engineering team. The company is currently completing comprehensive validation of its measurement technology, informed by world experts in blood pressure measurement science, and working with FDA for marketing clearance.